| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
H2N-PEG14-OH manufacturers
|
| | H2N-PEG14-OH Basic information |
| Product Name: | H2N-PEG14-OH | | Synonyms: | H2N-PEG14-OH;3,6,9,12,15,18,21,24,27,30,33,36,39-Tridecaoxahentetracontan-1-ol, 41-amino-;Inhibitor,Amino-PEG-14-alcohol,Amino PEG14 alcohol,PROTAC Linkers,inhibit,AminoPEG14alcohol;H2N-PEG14-OH/3,6,9,12,15,18,21,24,27,30,33,36,39-Tridecaoxahentetracontan-1-ol, 41-amino-;NH2-PEG14-OH;Amino-PEG13-ol | | CAS: | 34214-89-6 | | MF: | C28H59NO14 | | MW: | 633.77 | | EINECS: | | | Product Categories: | | | Mol File: | 34214-89-6.mol |  |
| | H2N-PEG14-OH Chemical Properties |
| Boiling point | 655.2±50.0 °C(Predicted) | | density | 1.102±0.06 g/cm3(Predicted) | | pka | 14.36±0.10(Predicted) |
| | H2N-PEG14-OH Usage And Synthesis |
| Uses | Amino-PEG14-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | H2N-PEG14-OH Preparation Products And Raw materials |
|